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Abstract. The aim of the present study was to assess the innocuity of isoflurane in rat lung and 
liver through histopathological examination. Experimental protocol: 20 female Wistar rats were 
divided intro 4 groups, each consisting of 5 individuals: control group, group I, II and III. Female 
rats from the control group were not exposed to any anesthetic treatment, while female rats from 
the other groups (I, II and III) were exposed to isoflurane three times, for 2 hours, every other 
day. Animals from the control group and group I were sacrificed immediately after the last 
exposure (0 h). Group II was sacrificed 6 hours after the last exposure and group III 24 hours after 
the last exposure. Fragments of the lung and liver were collected from the 20 female rats taken 
into study and then histologically processed (fixed in 10% buffered formalin and embedded in 
paraffin). After obtaining 5 µm thick sections, they were stained using Goldner’s Trichrome 
method. Histopathological examination of the tissue specimens showed no structural changes 
perceptible through light microscopy, thus showing that isoflurane did not exert a toxic action in 
these two organs. The present study proved a good innocuity of isoflurane in rat lung and liver. 
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Introduction. Isoflurane is an anesthetic utilized in both human and veterinary 
medicine. Its advantage resides in the fact that it favours the predictable and rapid adjustment of 
the depth of anesthesia. The anesthetic is administered through inhalation, directly in the 
respiratory system, being metabolised mainly in the liver, but also lung, kidney and 
gastrointestinal tract at a lower rate (Baden and Rice, 2000; Mazze and Fujinaga, 1989; Rehder et 
al.,1967; Stier et al., 1964). The elimination takes place preponderant in the lungs, but smaller 
amounts of anesthetic can be excreted through skin, milk, mucosae or urine (Muir et al., 2000). 
Aims and objectives. Considering that certain authors have made reference to the 
depression of the hepatic function and hepatocellular lesions (Tranquilli et al., 2007), as 
well as depression of the respiratory function (Cornick-Seahorn, 2001; Dugdale, 2010; 
Tranquilli et al., 2007) after isoflurane anesthesia, we proposed evaluating the liver and 
lung, histologically, on a murine experimental model. 
Materials and methods. 20 female Wistar rats, 12 weeks old, with an average 
weigh of 224 g were used in this study. They were divided into 4 groups: control, I, II and 
III. The control group did not undergo the anesthetic treatment, while groups I, II and III 
were submitted to isoflurane anesthesia thrice, for 2 hours, every other day.  
After the ending of the anesthetic treatment, the animals were sacrificed as 
follows: control group and group I immediately (0 h), group II after 6 hours and group III 
after 24 hours following the isoflurane administration. Liver and lung specimens were 
harvested. They were fixed in 10% buffered formaline and embedded in paraffin. 5 µm 
thick seriated sections were stained with Goldner’s Trichrome method.    
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Results and Discussions. No structural changes, preceptible through light 
microscopy, were pointed out in the histopathological examination, in none of the organs 
taken into study. Their aspects were comparable to the ones in the controul group. 
 
 
             
 
             
Fig. 1. 1 – Lung (control group); 2 – Liver (control group); 3 – Lung (group I);  
4 – Liver (group I); 5 – Lung (group II); 6 – Liver (group II); 7 – Lung (group III);  
8 – Liver (group III); Goldner’s trichrome stain; 1, 3, 5, 7 – 20X obj.; 2, 4, 6, 8 – 10X obj. 
 
Conclusions. The isoflurane administered through our experimental protocol did not 
exert a toxic action, perceptible through histopathological examination, on neither the lung 
nor the liver, thus proving a good innocuity of the isoflurane. 
 
REFERENCES 
 
1. Baden, J. M.; S. A. Rice (2000). Metabolism and toxicity of inhaled anesthetics, In: Miller 
R.D., ed. Anesthesia, 5th ed., p. 147-173, New York: Chruchill Livingstone. 
2. Cornick-Seahorn, J. L. (2001). Veterinary Anesthesia: The Practical Veterinarian Series, 
Publisher Elsevier Books, Oxford. 
3. Dugdale, A. (2010). Veterinary Anaesthesia – Principles to practice, Ed. Wiley-Blackwell, 
p. 64-75, United Kingdom. 
4. Mazze, R. I.; M. Fujinaga (1989). Biotransformation of inhalational anaesthetics, In: Nunn 
J.F., Utting J.E., Brown B.R., eds. General Anaesthesia, 5th ed., p. 73-85, London: Butterworths. 
5. Muir III W. W.; J. A. E. Hubbell; R. T. Skarda; R. M. Bednarski (2000). Handbook of 
Veterinary Anesthesia, Third Edition, Ed. Mosby, United States of America. 
6. Rehder, K.; J. Forbes; H. Alter; O. Hessler; A. Stier (1967). Halothane biotransformation in 
man: A quantitative study, Anesthesiology, 28:711-715. 
7. Stier, A.; H. Alter; O. Hessler; K. Rehider (1964), Urinary excretion of bromide in 
halothane anesthesia, Anesthesia and Analgesia, 43:723-728. 
8. Tranquilli, W. J.; J. C. Thurmon; K. A. Grimm (2007). Lumb & Jones’ Veterinary 
Anesthesia and Analgesia, Fourth Edition, Blackwell Publishing Professional, USA. 
1 
6 
2 3 4 
5 7 8 
